0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nimodipine Market Insights, Forecast to 2028
Published Date: November 2022
|
Report Code: QYRE-Auto-18D7023
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Nimodipine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Nimodipine Market Insights, Forecast to 2028

Code: QYRE-Auto-18D7023
Report
November 2022
Pages:87
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Nimodipine, sold under the brand name Nimotop among others, is a calcium channel blocker originally developed for the treatment of high blood pressure.
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Nimodipine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Nimodipine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Nimodipine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Nimodipine include Bayer, Azurity, Avet Pharmaceuticals Inc., Bionpharma, Reyoung Pharmaceutical and Cisen Pharmaceutical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Nimodipine manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Nimodipine market. Further, it explains the major drivers and regional dynamics of the global Nimodipine market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Bayer
Azurity
Avet Pharmaceuticals Inc.
Bionpharma
Reyoung Pharmaceutical
Cisen Pharmaceutical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Nimodipine Segment by Type

Capsule
Solution
Tablets

Nimodipine Segment by Application

Hospital
Pharmacy
Clinics
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nimodipine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Nimodipine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Nimodipine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Nimodipine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nimodipine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Nimodipine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Nimodipine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer, Azurity, Avet Pharmaceuticals Inc., Bionpharma, Reyoung Pharmaceutical and Cisen Pharmaceutical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Nimodipine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Nimodipine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nimodipine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Nimodipine Product Introduction
1.2 Market by Type
1.2.1 Global Nimodipine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsule
1.2.3 Solution
1.2.4 Tablets
1.3 Market by Application
1.3.1 Global Nimodipine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nimodipine Sales Estimates and Forecasts 2017-2028
2.2 Global Nimodipine Revenue Estimates and Forecasts 2017-2028
2.3 Global Nimodipine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nimodipine Sales by Region
2.4.1 Global Nimodipine Sales by Region (2017-2022)
2.4.2 Global Sales Nimodipine by Region (2023-2028)
2.5 Global Nimodipine Revenue by Region
2.5.1 Global Nimodipine Revenue by Region (2017-2022)
2.5.2 Global Nimodipine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nimodipine Sales by Manufacturers
3.1.1 Global Top Nimodipine Manufacturers by Sales (2017-2022)
3.1.2 Global Nimodipine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nimodipine in 2021
3.2 Global Nimodipine Revenue by Manufacturers
3.2.1 Global Nimodipine Revenue by Manufacturers (2017-2022)
3.2.2 Global Nimodipine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nimodipine Revenue in 2021
3.3 Global Nimodipine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nimodipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nimodipine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nimodipine Sales by Type
4.1.1 Global Nimodipine Historical Sales by Type (2017-2022)
4.1.2 Global Nimodipine Forecasted Sales by Type (2023-2028)
4.1.3 Global Nimodipine Sales Market Share by Type (2017-2028)
4.2 Global Nimodipine Revenue by Type
4.2.1 Global Nimodipine Historical Revenue by Type (2017-2022)
4.2.2 Global Nimodipine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nimodipine Revenue Market Share by Type (2017-2028)
4.3 Global Nimodipine Price by Type
4.3.1 Global Nimodipine Price by Type (2017-2022)
4.3.2 Global Nimodipine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nimodipine Sales by Application
5.1.1 Global Nimodipine Historical Sales by Application (2017-2022)
5.1.2 Global Nimodipine Forecasted Sales by Application (2023-2028)
5.1.3 Global Nimodipine Sales Market Share by Application (2017-2028)
5.2 Global Nimodipine Revenue by Application
5.2.1 Global Nimodipine Historical Revenue by Application (2017-2022)
5.2.2 Global Nimodipine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nimodipine Revenue Market Share by Application (2017-2028)
5.3 Global Nimodipine Price by Application
5.3.1 Global Nimodipine Price by Application (2017-2022)
5.3.2 Global Nimodipine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nimodipine Market Size by Type
6.1.1 North America Nimodipine Sales by Type (2017-2028)
6.1.2 North America Nimodipine Revenue by Type (2017-2028)
6.2 North America Nimodipine Market Size by Application
6.2.1 North America Nimodipine Sales by Application (2017-2028)
6.2.2 North America Nimodipine Revenue by Application (2017-2028)
6.3 North America Nimodipine Market Size by Country
6.3.1 North America Nimodipine Sales by Country (2017-2028)
6.3.2 North America Nimodipine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Nimodipine Market Size by Type
7.1.1 Europe Nimodipine Sales by Type (2017-2028)
7.1.2 Europe Nimodipine Revenue by Type (2017-2028)
7.2 Europe Nimodipine Market Size by Application
7.2.1 Europe Nimodipine Sales by Application (2017-2028)
7.2.2 Europe Nimodipine Revenue by Application (2017-2028)
7.3 Europe Nimodipine Market Size by Country
7.3.1 Europe Nimodipine Sales by Country (2017-2028)
7.3.2 Europe Nimodipine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nimodipine Market Size by Type
8.1.1 Asia Pacific Nimodipine Sales by Type (2017-2028)
8.1.2 Asia Pacific Nimodipine Revenue by Type (2017-2028)
8.2 Asia Pacific Nimodipine Market Size by Application
8.2.1 Asia Pacific Nimodipine Sales by Application (2017-2028)
8.2.2 Asia Pacific Nimodipine Revenue by Application (2017-2028)
8.3 Asia Pacific Nimodipine Market Size by Region
8.3.1 Asia Pacific Nimodipine Sales by Region (2017-2028)
8.3.2 Asia Pacific Nimodipine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Nimodipine Market Size by Type
9.1.1 Latin America Nimodipine Sales by Type (2017-2028)
9.1.2 Latin America Nimodipine Revenue by Type (2017-2028)
9.2 Latin America Nimodipine Market Size by Application
9.2.1 Latin America Nimodipine Sales by Application (2017-2028)
9.2.2 Latin America Nimodipine Revenue by Application (2017-2028)
9.3 Latin America Nimodipine Market Size by Country
9.3.1 Latin America Nimodipine Sales by Country (2017-2028)
9.3.2 Latin America Nimodipine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Nimodipine Market Size by Type
10.1.1 Middle East and Africa Nimodipine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nimodipine Revenue by Type (2017-2028)
10.2 Middle East and Africa Nimodipine Market Size by Application
10.2.1 Middle East and Africa Nimodipine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nimodipine Revenue by Application (2017-2028)
10.3 Middle East and Africa Nimodipine Market Size by Country
10.3.1 Middle East and Africa Nimodipine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nimodipine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Nimodipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Azurity
11.2.1 Azurity Corporation Information
11.2.2 Azurity Overview
11.2.3 Azurity Nimodipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Azurity Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Azurity Recent Developments
11.3 Avet Pharmaceuticals Inc.
11.3.1 Avet Pharmaceuticals Inc. Corporation Information
11.3.2 Avet Pharmaceuticals Inc. Overview
11.3.3 Avet Pharmaceuticals Inc. Nimodipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Avet Pharmaceuticals Inc. Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Avet Pharmaceuticals Inc. Recent Developments
11.4 Bionpharma
11.4.1 Bionpharma Corporation Information
11.4.2 Bionpharma Overview
11.4.3 Bionpharma Nimodipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bionpharma Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bionpharma Recent Developments
11.5 Reyoung Pharmaceutical
11.5.1 Reyoung Pharmaceutical Corporation Information
11.5.2 Reyoung Pharmaceutical Overview
11.5.3 Reyoung Pharmaceutical Nimodipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Reyoung Pharmaceutical Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Reyoung Pharmaceutical Recent Developments
11.6 Cisen Pharmaceutical
11.6.1 Cisen Pharmaceutical Corporation Information
11.6.2 Cisen Pharmaceutical Overview
11.6.3 Cisen Pharmaceutical Nimodipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cisen Pharmaceutical Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cisen Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nimodipine Industry Chain Analysis
12.2 Nimodipine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nimodipine Production Mode & Process
12.4 Nimodipine Sales and Marketing
12.4.1 Nimodipine Sales Channels
12.4.2 Nimodipine Distributors
12.5 Nimodipine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nimodipine Industry Trends
13.2 Nimodipine Market Drivers
13.3 Nimodipine Market Challenges
13.4 Nimodipine Market Restraints
14 Key Findings in The Global Nimodipine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Nimodipine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Capsule
    Table 3. Major Manufacturers of Solution
    Table 4. Major Manufacturers of Tablets
    Table 5. Global Nimodipine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Nimodipine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Nimodipine Sales by Region (2017-2022) & (K Units)
    Table 8. Global Nimodipine Sales Market Share by Region (2017-2022)
    Table 9. Global Nimodipine Sales by Region (2023-2028) & (K Units)
    Table 10. Global Nimodipine Sales Market Share by Region (2023-2028)
    Table 11. Global Nimodipine Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Nimodipine Revenue Market Share by Region (2017-2022)
    Table 13. Global Nimodipine Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Nimodipine Revenue Market Share by Region (2023-2028)
    Table 15. Global Nimodipine Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Nimodipine Sales Share by Manufacturers (2017-2022)
    Table 17. Global Nimodipine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Nimodipine Revenue Share by Manufacturers (2017-2022)
    Table 19. Nimodipine Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global Nimodipine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Nimodipine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nimodipine as of 2021)
    Table 22. Nimodipine Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Nimodipine Product Offered
    Table 24. Date of Manufacturers Enter into Nimodipine Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Nimodipine Sales by Type (2017-2022) & (K Units)
    Table 27. Global Nimodipine Sales by Type (2023-2028) & (K Units)
    Table 28. Global Nimodipine Sales Share by Type (2017-2022)
    Table 29. Global Nimodipine Sales Share by Type (2023-2028)
    Table 30. Global Nimodipine Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Nimodipine Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Nimodipine Revenue Share by Type (2017-2022)
    Table 33. Global Nimodipine Revenue Share by Type (2023-2028)
    Table 34. Nimodipine Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global Nimodipine Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global Nimodipine Sales by Application (2017-2022) & (K Units)
    Table 37. Global Nimodipine Sales by Application (2023-2028) & (K Units)
    Table 38. Global Nimodipine Sales Share by Application (2017-2022)
    Table 39. Global Nimodipine Sales Share by Application (2023-2028)
    Table 40. Global Nimodipine Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Nimodipine Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Nimodipine Revenue Share by Application (2017-2022)
    Table 43. Global Nimodipine Revenue Share by Application (2023-2028)
    Table 44. Nimodipine Price by Application (2017-2022) & (US$/Unit)
    Table 45. Global Nimodipine Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 46. North America Nimodipine Sales by Type (2017-2022) & (K Units)
    Table 47. North America Nimodipine Sales by Type (2023-2028) & (K Units)
    Table 48. North America Nimodipine Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Nimodipine Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Nimodipine Sales by Application (2017-2022) & (K Units)
    Table 51. North America Nimodipine Sales by Application (2023-2028) & (K Units)
    Table 52. North America Nimodipine Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Nimodipine Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Nimodipine Sales by Country (2017-2022) & (K Units)
    Table 55. North America Nimodipine Sales by Country (2023-2028) & (K Units)
    Table 56. North America Nimodipine Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Nimodipine Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Nimodipine Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Nimodipine Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Nimodipine Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Nimodipine Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Nimodipine Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Nimodipine Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Nimodipine Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Nimodipine Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Nimodipine Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Nimodipine Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Nimodipine Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Nimodipine Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Nimodipine Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Nimodipine Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Nimodipine Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Nimodipine Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Nimodipine Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Nimodipine Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Nimodipine Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Nimodipine Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Nimodipine Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Nimodipine Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Nimodipine Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Nimodipine Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Nimodipine Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Nimodipine Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Nimodipine Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Nimodipine Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Nimodipine Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Nimodipine Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Nimodipine Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Nimodipine Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Nimodipine Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Nimodipine Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Nimodipine Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Nimodipine Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Nimodipine Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Nimodipine Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Nimodipine Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Nimodipine Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Nimodipine Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Nimodipine Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Nimodipine Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Nimodipine Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Nimodipine Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Nimodipine Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Nimodipine Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Nimodipine Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Bayer Corporation Information
    Table 107. Bayer Description and Major Businesses
    Table 108. Bayer Nimodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. Bayer Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Bayer Recent Developments
    Table 111. Azurity Corporation Information
    Table 112. Azurity Description and Major Businesses
    Table 113. Azurity Nimodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. Azurity Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Azurity Recent Developments
    Table 116. Avet Pharmaceuticals Inc. Corporation Information
    Table 117. Avet Pharmaceuticals Inc. Description and Major Businesses
    Table 118. Avet Pharmaceuticals Inc. Nimodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. Avet Pharmaceuticals Inc. Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Avet Pharmaceuticals Inc. Recent Developments
    Table 121. Bionpharma Corporation Information
    Table 122. Bionpharma Description and Major Businesses
    Table 123. Bionpharma Nimodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. Bionpharma Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Bionpharma Recent Developments
    Table 126. Reyoung Pharmaceutical Corporation Information
    Table 127. Reyoung Pharmaceutical Description and Major Businesses
    Table 128. Reyoung Pharmaceutical Nimodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. Reyoung Pharmaceutical Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Reyoung Pharmaceutical Recent Developments
    Table 131. Cisen Pharmaceutical Corporation Information
    Table 132. Cisen Pharmaceutical Description and Major Businesses
    Table 133. Cisen Pharmaceutical Nimodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 134. Cisen Pharmaceutical Nimodipine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Cisen Pharmaceutical Recent Developments
    Table 136. Key Raw Materials Lists
    Table 137. Raw Materials Key Suppliers Lists
    Table 138. Nimodipine Distributors List
    Table 139. Nimodipine Customers List
    Table 140. Nimodipine Market Trends
    Table 141. Nimodipine Market Drivers
    Table 142. Nimodipine Market Challenges
    Table 143. Nimodipine Market Restraints
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nimodipine Product Picture
    Figure 2. Global Nimodipine Market Share by Type in 2021 & 2028
    Figure 3. Capsule Product Picture
    Figure 4. Solution Product Picture
    Figure 5. Tablets Product Picture
    Figure 6. Global Nimodipine Market Share by Application in 2021 & 2028
    Figure 7. Hospital
    Figure 8. Pharmacy
    Figure 9. Clinics
    Figure 10. Others
    Figure 11. Nimodipine Report Years Considered
    Figure 12. Global Nimodipine Sales 2017-2028 (K Units)
    Figure 13. Global Nimodipine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Nimodipine Revenue 2017-2028 (US$ Million)
    Figure 15. Global Nimodipine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Nimodipine Sales Market Share by Region (2017-2022)
    Figure 17. Global Nimodipine Sales Market Share by Region (2023-2028)
    Figure 18. North America Nimodipine Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Nimodipine Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Nimodipine Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Nimodipine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Nimodipine Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Nimodipine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Nimodipine Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Nimodipine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Nimodipine Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Nimodipine Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Nimodipine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Nimodipine in the World: Market Share by Nimodipine Revenue in 2021
    Figure 30. Global Nimodipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Nimodipine Sales Market Share by Type (2017-2028)
    Figure 32. Global Nimodipine Revenue Market Share by Type (2017-2028)
    Figure 33. Global Nimodipine Sales Market Share by Application (2017-2028)
    Figure 34. Global Nimodipine Revenue Market Share by Application (2017-2028)
    Figure 35. North America Nimodipine Sales Market Share by Type (2017-2028)
    Figure 36. North America Nimodipine Revenue Market Share by Type (2017-2028)
    Figure 37. North America Nimodipine Sales Market Share by Application (2017-2028)
    Figure 38. North America Nimodipine Revenue Market Share by Application (2017-2028)
    Figure 39. North America Nimodipine Sales Share by Country (2017-2028)
    Figure 40. North America Nimodipine Revenue Share by Country (2017-2028)
    Figure 41. United States Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Nimodipine Sales Market Share by Type (2017-2028)
    Figure 44. Europe Nimodipine Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Nimodipine Sales Market Share by Application (2017-2028)
    Figure 46. Europe Nimodipine Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Nimodipine Sales Share by Country (2017-2028)
    Figure 48. Europe Nimodipine Revenue Share by Country (2017-2028)
    Figure 49. Germany Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 50. France Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Nimodipine Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Nimodipine Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Nimodipine Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Nimodipine Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Nimodipine Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Nimodipine Revenue Share by Region (2017-2028)
    Figure 60. China Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 63. India Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 65. China Taiwan Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Nimodipine Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Nimodipine Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Nimodipine Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Nimodipine Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Nimodipine Sales Share by Country (2017-2028)
    Figure 74. Latin America Nimodipine Revenue Share by Country (2017-2028)
    Figure 75. Mexico Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 78. Colombia Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Nimodipine Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Nimodipine Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Nimodipine Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Nimodipine Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Nimodipine Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Nimodipine Revenue Share by Country (2017-2028)
    Figure 85. Turkey Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 87. UAE Nimodipine Revenue (2017-2028) & (US$ Million)
    Figure 88. Nimodipine Value Chain
    Figure 89. Nimodipine Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS